- What does the 2021 Federal budget hold in terms of health reforms?
- What big players are involved in and how have they performed?
- What’s the market performance of these stocks been post the Budget?
With the 2021 Budget out, the New Zealand Government has made active promises about changing the healthcare conditions in the country for better. Right from helping district health boards to establishing the Maori Health board, the government has big plans. Here are certain stocks that have all eyes fixed on them. Let’s have a look at how they have fared recently.
Image Source: Copyright © 2021 Kalkine Media
TruScreen Limited (NZX:TRU)
It offers critical screening solutions to determine the presence of cancer and other diseases It has recently made public its newsletter according to which, its dual-listing situation with the ASX and the NZX got it a capital raise of $2M. There is a clinical trial underway in Saudi Arabia right now, reads the newsletter.
On May 26, TruScreen Limited traded down by more than 2% at NZ$0.790 at the time of writing.
AFT Pharmaceuticals (NZX:AFT)
As the name suggests, this is a pharmaceutical company with operations spanning across the country. It has announced in its financial results up to 31 March 2021 that the Company had witnessed good business despite the world economy taking a tumble. Having made a record revenue of NZ$113.1M, it has witnessed growth in different markets across the world.
On May 26, AFT Pharmaceuticals traded flat at NZ$4.680, at the time of writing.
Fisher and Paykel Healthcare Corporation Limited (NZX:FPH)
This Company offers critical mechanical equipment for the medical use for both home and hospitals. It has announced an investor series to be held virtually from the 1st to 3rd of June 2021. This will give various participants for countries involved to understand the plan and structure of future plans and how much profit it could potentially earn.
On May 26, Fisher and Paykel Healthcare Corporation Limited traded at NZ$32.290, down by 1% at the time of writing.
RUA Bioscience Limited (NZX:RUA)
This Company develops cannabis-related medical products. It has recently announced an agreement with Medbloom Limited. This is to attain raw biomass supply from them for the purpose of alternative growers to help in supplementing what the company currently grows in its Ruatorea facility.
On May 26, RUA Bioscience Limited traded flat at NZ$0.405, at the time of writing.
Blis Technologies Limited (NZX:BLT)
This company is known to create probiotic strains, helpful in skincare and healthcare. It has recently announced the appointment of Laura Grant for the position of the E-commerce Director. She was previously with Lion as its e-commerce National Account Manager. The CEO, Brian Watson, welcomed her to the new position.
On May 26, Blis Technologies Limited traded at NZ$0.063, down by 1.59% at the time of writing.